Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome.

Ballou, Sarah; Haas, Julia W; Iturrino, Johanna; Nee, Judy; Kirsch, Irving; Rangan, Vikram; Cheng, Vivian; Lembo, Anthony; Kaptchuk, Ted J; Kelley, John M

Ballou, Sarah; Haas, Julia W; Iturrino, Johanna; Nee, Judy; Kirsch, Irving; Rangan, Vikram; Cheng, Vivian; Lembo, Anthony; Kaptchuk, Ted J; Kelley, John M.

Affiliation

Ballou S; From the Division of Gastroenterology (Ballou, Haas, Iturrino, Nee, Rangan, Cheng, Lembo) and Program in Placebo Studies (Kirsch, Kaptchuk, Kelley), Beth Israel Deaconess Medical Center/Harvard Medical School, Boston; and Department of Psychology (Kelley), Endicott College, Beverly, Massachusetts.

Psychosom Med ; 84(6): 738-746, 2022.

Article in En | MEDLINE | ID: mdl-35412513

Subject(s)

Irritable Bowel Syndrome; Adult; Anxiety/drug therapy; Anxiety/psychology; Catastrophization; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome/drug therapy; Male; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Irritable Bowel Syndrome Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Psychosom Med Year: 2022 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google